Chase AIPricingFAQs
Display currency
Loading news…

BBOT

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Palo Alto, California, United States Founded 2014 51-100 employees For Profit

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Ticker
BBOT
NASDAQ
Patents
1
4 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
BBOT
Exchange
NASDAQ
IPO date
Aug 11, 2025
Raised at IPO
$184M
Valuation at IPO
$202M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Patents granted
1
Trademarks
4
Top patent class
Organic Chemistry

Company Info

Founded
2014
Employees
51-100
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
37
HQ
Palo Alto, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast
Exit date
Aug 11, 2025

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
-0.2
Trend (30d)
-1.2
Trend (90d)
-0.3
Last leadership hire
Apr 23, 2026

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to BBOT

Loading news…

FAQs about BBOT

People who checked this page also checked these

Browse the full Acquirezy directory.
BBOT - Company Profile, Full Acquisitions List, Funding and Investments